These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6830376)

  • 1. Non-Hodgkin's lymphomas after treatment of Hodgkin's disease.
    Fisher RI
    Arch Intern Med; 1983 Mar; 143(3):427. PubMed ID: 6830376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Second tumors following treatment of Hodgkin's disease].
    Somers R; van Leeuwen FE; Taal BG; van Heerde P; Coster B; Hart AA
    Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1358-62. PubMed ID: 3412505
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-Hodgkin's lymphoma following treatment for Hodgkin's disease. Case report and review of the literature.
    Rubins J; Sischy B; Lee JC
    Am J Clin Pathol; 1980 Nov; 74(5):696-700. PubMed ID: 7004167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tentative pathogenetic interpretation of some cytoimmunological aspects in malignant lymphomas, with particular reference to Hodgkin's disease.
    Mauri C; Quaglino D; De Pasquale A
    Haematologica; 1979 Dec; 64(6):826-44. PubMed ID: 121095
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hodgkin's disease and non-Hodgkin's lymphoma occurring simultaneously].
    Bosch F; Ordi J; López-Guillermo A; Campo E; Montserrat E; Rozman C
    Med Clin (Barc); 1993 May; 100(20):788-90. PubMed ID: 8321056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Musculoskeletal lymphomas].
    Ludwig K
    Radiologe; 2002 Dec; 42(12):988-92. PubMed ID: 12486552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Hodgkin's disease.
    Meyer SA; Thar T
    Am Fam Physician; 1981 Nov; 24(5):217-21. PubMed ID: 7293915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphomatoid papulosis evolving into malignant lymphoma. Clinico-pathological and immunohistochemical study of 3 cases].
    Bustos de Abajo M; Serrano Ortega S; Medina Cano MT; Aguilar Peña D; Gutiérrez Salmerón MT; Gómez Morales M; García del Moral R
    Med Clin (Barc); 1993 Feb; 100(6):220-2. PubMed ID: 8429728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
    Kaźmierczak M; Komarnicki M; Kroll R
    Acta Haematol Pol; 1995; 26(3):311-3. PubMed ID: 8525778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease and nodular lymphoma.
    Cardinali G; Eusebi V
    Haematologica; 1975 Jun; 60(2):236-40. PubMed ID: 808455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hodgkin's disease and idiopathic cardiomyopathy (author's transl)].
    Congy F; Dardenne M; Coudurier P; Moulias R; Loeper J
    Sem Hop; 1982 Jan; 58(2):108-10. PubMed ID: 6276993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phagocytosis measurement in Hodgkin's disease and Non-Hodgkin lymphoma-patients with a new radiometric assay (author's transl)].
    Süss J; Balázs C; Bakács T
    Allerg Immunol (Leipz); 1982; 28(1):56-63. PubMed ID: 6214175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
    Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute non-lymphoblastic leukemias during Hodgkin's and non-Hodgkin's lymphomas in remission: a distinct cytogenetic entity].
    Gyger M; Forest L
    Union Med Can; 1980 Aug; 109(8):1212-5. PubMed ID: 7210330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Composite gastric lymphoma: MALT gastric lymphoma associated with Hodgkin's disease].
    Martín Pérez E; Fernández Arjona M; Ortega López M; Acevedo A
    Rev Esp Enferm Dig; 1993 Jul; 84(1):46-9. PubMed ID: 8357645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.